Antineoplastons: What They Are and Why They Matter

You've probably heard the term antineoplastons tossed around in cancer forums or news stories. In short, they are tiny molecules made from amino acids and other natural compounds. Dr. Stanislaw Burzynski, a Polish-American researcher, says they can stop cancer cells from growing and even shrink tumors. The idea sounds exciting, but the reality is a lot more complicated.

How Antineoplastons Claim to Work

According to the Burzynski Clinic, antineoplastons target the genetic errors that make cancer cells divide uncontrollably. They’re supposed to correct those errors, push the bad cells into a normal state, or trigger them to die off. The therapy is given through IV infusions or oral pills, and each patient gets a custom mix based on their specific cancer type.

What the Research Actually Shows

Official studies on antineoplastons are limited and controversial. The FDA has never approved them, and many scientific reviews say there’s not enough solid data to prove they work. Some small trials report tumor shrinkage, but those results haven’t been replicated in larger, peer‑reviewed studies. In short, the evidence is weak, and the medical community remains skeptical.

If you’re considering antineoplastons, there are a few practical things to keep in mind. First, the treatment can be expensive—often running into tens of thousands of dollars per year. Second, side effects like fatigue, nausea, and liver enzyme changes have been reported. Third, because the therapy isn’t regulated, the quality and consistency of the product can vary.

It’s also worth noting that many hospitals and cancer centers offer proven alternatives, such as chemotherapy, immunotherapy, and targeted drugs, that have undergone rigorous testing. Before you sign up for any experimental option, talk to an oncologist you trust and ask about the latest standard‑of‑care options for your diagnosis.

Bottom line: antineoplastons are an alternative cancer approach that some patients find interesting, but the scientific backing is thin. Understanding the costs, risks, and lack of FDA approval can help you make a more informed decision. Always weigh experimental treatments against proven therapies and never skip professional medical advice.